The Next Generation Of Biodefense: AI, CRISPR & Rapid Diagnostics | Jared Bauer - CEO, Seek Labs

Send us Fan MailWhat if the next pandemic could be identified, diagnosed, and targeted with programmable CRISPR therapeutics before it spreads globally? That’s exactly what Seek Labs is trying to build.Jared Bauer is CEO of Seek Labs ( https://seeklabs.com/ ), a clinical-stage TechBio company developing an integrated platform that combines AI-driven genomic intelligence, rapid field diagnostics, and CRISPR-based therapeutics designed to identify and potentially counter emerging pathogens faster than ever before.In a world where outbreaks can spread globally before traditional systems even identify the threat - as we saw with COVID and more recently with delayed hantavirus confirmation cases - Seek Labs is asking a bold question: what if diagnostics and therapeutics could be programmed and deployed at the speed of software?Jared is also Chairman of BioHive Utah ( https://www.biohive.com/ ), one of the fastest-growing life science ecosystems in the United States, and has spent his career at the intersection of biotech innovation, AI, diagnostics, and public health preparedness.We discuss AI-driven drug discovery, CRISPR therapeutics, programmable outbreak response, biodefense infrastructure, and what the next generation of pandemic preparedness may actually look like.#SeekLabs #JaredBauer #CRISPR #AI #Biotech #PandemicPreparedness #BioDefense #Diagnostics #Therapeutics #GeneEditing #SyntheticBiology #InfectiousDisease #FutureOfMedicine #HealthcareInnovation #PrecisionMedicine #Biotechnology #BARDA #ARPAH #DiseaseSurveillance #TechBio #OutbreakResponse #Biosecurity #AIinHealthcare #MedicalInnovation #PodcastSupport the show